摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-硝基-4-二氢色原酮 | 22528-79-6

中文名称
7-硝基-4-二氢色原酮
中文别名
2,3-二氢-7-硝基-4H-1-苯并吡喃-4-酮
英文名称
6-nitro-4-chromanone
英文别名
7-nitrochroman-4-one;7-nitro-4-chromanone;7-nitro-2,3-dihydrochromen-4-one
7-硝基-4-二氢色原酮化学式
CAS
22528-79-6
化学式
C9H7NO4
mdl
MFCD09744057
分子量
193.159
InChiKey
LSJDOYAXWWYHPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    378.7±42.0 °C(Predicted)
  • 密度:
    1.424±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    72.1
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2932999099

SDS

SDS:d680fe3650b1122a1a1be4f97a824c53
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-硝基-4-二氢色原酮tris-(dibenzylideneacetone)dipalladium(0)铁粉potassium carbonate氯化铵4,5-双二苯基膦-9,9-二甲基氧杂蒽三氟乙酸 作用下, 以 1,4-二氧六环甲醇二氯甲烷 为溶剂, 反应 3.0h, 生成 2-(2,6-difluorophenyl)-4-((4-oxochroman-7-yl)amino)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one
    参考文献:
    名称:
    TYK2 INHIBITORS AND USES THEREOF
    摘要:
    本发明提供了化合物、其组合物以及使用这些化合物来抑制TYK2并治疗TYK2介导的疾病的方法。
    公开号:
    US20160251376A1
  • 作为产物:
    参考文献:
    名称:
    An efficient synthesis of 4-chromanones
    摘要:
    A two step efficient and practical synthesis of a variety of 4-chromanones is described. Phenols undergo a Michael addition to acrylonitriles in the presence of catalytic amounts of potassium carbonate and tert-butanol to generate the corresponding 3-aryloxypropanenitriles in 50-93% yields. Treatment of the resulting aryloxypropionitriles with 1.5 equiv of TfOH and 5 equiv of TFA, followed by an aqueous work up afforded 4-chromanones in moderate to excellent yields. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2011.07.018
点击查看最新优质反应信息

文献信息

  • Substituted pyrazolyl compounds for the treatment of inflammation
    申请人:——
    公开号:US20030114432A1
    公开(公告)日:2003-06-19
    The present invention relates to substituted pyrazolyl derivatives, compositions comprising such, intermediates, methods of making substituted pyrazolyl derivatives, and methods for treating cancer, inflammation, and inflammation-associated disorders, such as arthritis.
    本发明涉及取代吡唑基衍生物,包含这种衍生物的组合物,中间体,制备取代吡唑基衍生物的方法,以及治疗癌症、炎症和与炎症相关的疾病,如关节炎的方法。
  • A versatile approach to flavones via a one-pot Pd(<scp>ii</scp>)-catalyzed dehydrogenation/oxidative boron-Heck coupling sequence of chromanones
    作者:Jun Lee、Jihyun Yu、Seung Hwan Son、Jinyuk Heo、Taelim Kim、Ji-Young An、Kyung-Soo Inn、Nam-Jung Kim
    DOI:10.1039/c5ob01911g
    日期:——

    A variety of flavones were expediently synthesized from readily accessible chromanones via a one-pot sequence involving Pd(ii)-catalyzed dehydrogenation and oxidative boron-Heck coupling with arylboronic acid pinacol esters.

    通过Pd(II)催化的脱氢和氧化硼-Heck偶联反应,利用易得的色酮,方便地合成了多种黄酮类化合物
  • Amidine derivatives and platelet aggregation inhibitor containing the
    申请人:Mitsui Toatsu Chemicals, Inc.
    公开号:US05719145A1
    公开(公告)日:1998-02-17
    The invention relates to a substituted amidine derivative which has an excellent platelet aggregation inhibiting action on the basis of fibrinogen antagonism and is particularly excellent in effectiveness on oral administration, and the platelet aggregation inhibitor containing the substituted amidine derivative of the invention as an effective ingredient is effective for prevention and treatment of thrombosis, and restenosis or reocclusion after percutaneous transluminal coronary angioplasty or percutaneous transluminal coronary recanalization.
    该发明涉及一种替代的酰胺基衍生物,其基于纤维蛋白原拮抗具有出色的抑制血小板聚集作用,特别在口服给药方面具有出色的效果,含有该替代酰胺基衍生物的血小板聚集抑制剂作为有效成分对预防和治疗血栓形成、经皮 transluminal 冠状动脉成形术或经皮 transluminal 冠状动脉再通术后的再狭窄或再闭塞具有有效性。
  • Sequential One-Pot Access to Molecular Diversity through Aniline Aqueous Borylation
    作者:William Erb、Mathieu Albini、Jacques Rouden、Jérôme Blanchet
    DOI:10.1021/jo501665e
    日期:2014.11.7
    On the basis of our recently reported aniline aqueous borylation, molecular diversity was achieved in a one-pot process by combining other reactions such as esterification, Suzuki-Miyaura coupling, hydrogenolysis, or Petasis borono-Mannich.
  • Amidine derivatives and platelet aggregation inhibitor containing the same
    申请人:MITSUI CHEMICALS, INC.
    公开号:EP0760364B1
    公开(公告)日:2000-07-19
查看更多